SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
Commission File Number 0-16335
NOTIFICATION OF LATE FILING
(Check One): [ ] Form 10-K and Form 10-KSB [ ] Form 11-K [ ] Form 20-F
[X] Form 10-Q and Form 10-QSB [ ] Form N-SAR
For Period Ended: March 31, 2000
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
Read attached instruction sheet before preparing form. Please print or
type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:
PART I
REGISTRANT INFORMATION
BIO-MEDICAL AUTOMATION, INC.
- ------------------------------------------------------------------------------
Full Name of Registrant
- ------------------------------------------------------------------------------
Former Name if Applicable
900 Third Avenue, Suite 201
- ------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
New York, New York 10022
- ------------------------------------------------------------------------------
City, State and Zip Code
<PAGE>
PART II
RULE 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate.)
[X] (a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable effort or
expense;
[X] (b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or
portion thereof will be filed on or before the 15th calendar day
following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof will
be filed on or before the fifth calendar day following the
prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail why the Form 10-K, 11-K, 20-F 10-Q, N-SAR
or the transition report portion thereof could not be filed within the
prescribed time period. (Attach extra sheets if needed.)
As previously disclosed in the registrants Form 8-K, dated April 5, 2000, there
was a change in control of the registrant effective on March 25, 2000. As such,
the registrant's independent auditors have not been able to complete the
procedures necessary to review the required financial information for the
registrant to complete its Quarterly Report on Form 10-QSB for the period ended
March 31, 2000. Thus, the registrant requires additional time to properly
complete and file its Form 10-QSB for the quarter ended March 31, 2000.
For the reasons set forth above, the registrant cannot timely file its Quarterly
Report on Form 10-QSB for the period ended March 31, 2000 without unreasonable
effort or expense. The registrant will file its Form 10-KSB no later than the
fifth day after the due date of the Form 10-QSB.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Steven N. Bronson, President (212) 610-2778
--------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
<PAGE>
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is
no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof?
[X] Yes [ ] No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
On March 9, 1999, the registrant completed the sale of substantially
all of its assets to JOT Automation, Inc. This transaction is more completely
described in the registrant's Current Report on Form 8-K, reporting events of
March 9, 1999, as amended, and the registrant's Annual Report on Form 10-K for
the fiscal year ended December 31, 1998, which reports are incorporated herein
by reference. As a result of the sale of substantially all of its assets of the
registrant on March 9, 1999, there will be a change in the results of operations
from the corresponding period for the last fiscal year which will be reflected
by the earnings statements to be included in the Quarterly Report on Form 10-QSB
for the period ended March 31, 2000.
BIO-MEDICAL AUTOMATION, INC.
- ------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Dated: May 12, 2000 By /s/ Steven N. Bronson
- ------------------- -----------------------------
Steven N. Bronson, President
INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and
title of the person signing the form shall be typed or printed beneath the
signature. If the statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer), evidence of
the representative's authority to sign on behalf of the registrant shall be
filed with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (see 18 U.S.C. Section 1001).
